当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Microvascular Research杂志
Microvascular Research
基本信息
期刊名称 Microvascular Research
MICROVASC RES
期刊ISSN 0026-2862
期刊官方网站 https://www.sciencedirect.com/journal/microvascular-research
是否OA No
出版商 Academic Press Inc.
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 1968
年文章数 118
影响因子 2.9(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 PERIPHERAL VASCULAR DISEASE 外周血管病4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 6.0 0.731 0.785
Medicine
Cardiology and Cardiovascular Medicine
85/387 78%
Biochemistry, Genetics and Molecular Biology
Biochemistry
193/438 56%
Biochemistry, Genetics and Molecular Biology
Cell Biology
161/285 43%
补充信息
自引率 3.4%
H-index 81
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0026-2862%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/MVR
收稿范围
Microvascular Research is dedicated to the dissemination of fundamental information related to the microvascular field. Full-length articles presenting the results of original research and brief communications are featured.

Research Areas include:
• Angiogenesis
• Biochemistry
• Bioengineering
• Biomathematics
• Biophysics
• Cancer
• Circulatory homeostasis
• Comparative physiology
• Drug delivery
• Neuropharmacology
• Microvascular pathology
• Rheology
• Tissue Engineering

US National Institutes of Health (NIH) voluntary posting ("Public Access") policy

Microvascular Research and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors
收录体裁
Research Paper
Short Communications
Technical Reports.
Correspondence
投稿指南 https://www.sciencedirect.com/journal/microvascular-research/publish/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/microvascular-research/0026-2862/guide-for-authors
编辑信息

Editor-in-Chief

P.A. D'Amore

Harvard Medical School, Boston, Massachusetts, United States

Associate Editors

M.E. Beckner

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

S. Bertuglia

Institute of Clinical Physiology National Research Council, Pisa, Italy

M. Boric

Pontifical Catholic University of Chile, Santiago, Chile

E. Bouskela

Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

D.A. Cheresh

Scripps Research Institute, La Jolla, California, United States

P. Conti

Gabriele d'Annunzio University of Chieti and Pescara, Chieti, Italy

E. Dejana

FIRC Institute of Molecular Oncology, Milano, Italy

M.W. Dewhirst

Duke University, Durham, North Carolina, United States

P. Dore-Duffy

Wayne State University School of Medicine, Detroit, Michigan, United States

W.N. Duran

Rutgers Biomedical and Health Sciences, Newark, New Jersey, United States

A.M. Dvorak

BETH ISRAEL DEACONESS MEDICAL CENTER, Boston, Massachusetts, United States

D. English

University of South Florida, Tampa, Florida, United States

J.C. Frisbee

West Virginia University, Morgantown, West Virginia, United States

K. Fujiwara

University of Rochester, Rochester, New York, United States

P. Gaehtgens

Free University of Berlin, Berlin, Germany

M.S. Goligorsky

Stony Brook University, Stony Brook, New York, United States

H.B. Hechtman

Harvard Medical School, Boston, Massachusetts, United States

I.M. Herman

Tufts University School of Medicine, Boston, Massachusetts, United States

R. Jain, PhD

Harvard Medical School, Boston, Massachusetts, United States

T.S. Kern

Case Western Reserve University, Cleveland, Ohio, United States

B. Klitzman

Duke University, Durham, North Carolina, United States

A. Koller

New York Medical College, Valhalla, New York, United States

P. Kubes

University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

R. Levick

University of London St George's, London, United Kingdom

K. Ley

Virginia Commonwealth University Department of Biomedical Engineering, Richmond, Virginia, United States

G.A. Lutty

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

J. Martins e Silva

University of Lisbon, Lisboa, Portugal

W.G. Mayhan

UNIVERSITY OF NEBRASKA MEDICAL CENTER, Omaha, Nebraska, United States

K.C. Norrby

University of Gothenburg, Goteborg, Sweden

J.S. Pachter

UConn Health Division of Hypertension and Clinical Pharmacology, Farmington, Connecticut, United States

R. Pasqualini

UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, Houston, Texas, United States

A.S. Popel

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

M.J. Reed

University of Washington, Seattle, Washington, United States

P.J. Schultz

University of Minnesota, Minneapolis, Minnesota, United States

H. Sinzinger

University of Vienna, Wien, Austria

W.G. Stetler-Stevenson

National Cancer Institute, Bethesda, Maryland, United States

T. Stevens

University of South Alabama College of Medicine, Mobile, Alabama, United States

M. Townsley

University of Alabama at Birmingham, Birmingham, Alabama, United States

R. Tuma

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States

K. Tyml

Western University, London, Ontario, Canada

B. Ward

Queen Mary University of London, London, United Kingdom

S.Y. Yuan

Texas A&M University Health Sciences Center, Temple, Texas, United States


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug